Brief: Caribou Biosciences Announces The FDA Granted Regenerative Medicine Advanced Therapy (Rmat) And Fast Track Designations To Cb-010, An Allogeneic Anti-Cd19 Car-T Cell Therapy
29/11/2022 14:05
Nov 29 (Reuters) - Caribou Biosciences Inc CRBU.O :
* CARIBOU BIOSCIENCES ANNOUNCES THE FDA GRANTED REGENERATIVE
MEDICINE ADVANCED THERAPY (RMAT) AND FAST TRACK DESIGNATIONS TO
CB-010, AN ALLOGENEIC ANTI-CD19 CAR-T CELL THERAPY
Source text for Eikon: ID:nGNX4255vm
Further company coverage: CRBU.O
((Reuters.Briefs@thomsonreuters.com;;))